Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10445571 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature